It is a link to move within the page

Press Release

May 8, 2003

Torii Pharmaceutical Co., Ltd.
Notice Concerning Acquisition of the Company's Own Shares in the Market
(Based on Japanese Commercial Code Article 210 Concerning Share Acquisition)
Torii Pharmaceutical Co., Ltd. announced that at the Board of Directors' Meeting held on May 8, 2003, a resolution was approved to propose to the 111th ordinary general meeting of shareholders on June 24, 2003 the acquisition of its own shares in accordance with Japanese Commercial Code Article 210, with details as follows.

1. Reason for shares acquisition
  In order to implement flexible capital policies in accordance with the business environment.

2. Details of the acquisition
(1) Type of shares to be acquired : common stock
(2) Total number of shares to be acquired : 1,000,000 shares(maximum)
(3.5% of total issued shares)
(3) Total value of shares to be acquired: ¥1,800,000,000 (maximum)

The above proposal, "Acquisition of the Company's Own Shares," is subject to approval at the 111th ordinary general meeting of shareholders to be held on June 24, 2003.

It is the end of the page